Aquestive Therapeutics Inc
AQST6.040USD
-0.090-1.47%
收盤 11/07, 16:00（美東）報價延遲15分鐘
734.82M總市值
虧損本益比TTM
關於 Aquestive Therapeutics Inc 公司
Aquestive Therapeutics, Inc. 是一家制藥公司。該公司正在開發藥品，通過給藥方式輸送複雜分子，以替代侵入性和不方便的標準護理療法。該公司正在推進治療嚴重過敏反應（包括過敏反應）的產品線。該公司還開發了專注於治療中樞神經系統 (CNS) 疾病的產品線。其 PharmFilm 技術由專有聚合物組合物組成，這些組合物可用作成膜劑來固定活性藥物成分 (API) 和賦形劑。其產品組合和產品線包括 Anaphylm、AQST-108 和 Adrenaverse。其 CNS 候選產品包括 Libervant。該公司的許可商業產品和候選產品及其他產品包括 Suboxone、Exservan、KYNMOBI、Zuplenz、Azstarys、Libervant 和 Sympazan。Anaphylm 是一種非基於設備的口服腎上腺素候選產品。
Aquestive Therapeutics Inc簡介
公司代碼AQST
公司名稱Aquestive Therapeutics Inc
上市日期Jul 25, 2018
CEOMr. Daniel Barber
員工數量142
證券類型Ordinary Share
年結日Jul 25
公司地址30 Technology Dr
城市WARREN
上市交易所NASDAQ Global Market Consolidated
國家United States of America
郵編07059-5166
電話19089411900
網址https://aquestive.com/
公司代碼AQST
上市日期Jul 25, 2018
CEOMr. Daniel Barber
Aquestive Therapeutics Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Daniel Barber
Mr. Daniel Barber
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.76M
-4.97%
Ms. Lori J. Braender, J.D.
Ms. Lori J. Braender, J.D.
Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
649.24K
+36.11%
Dr. Carl N. Kraus, M.D.
Dr. Carl N. Kraus, M.D.
Chief Medical Officer
Chief Medical Officer
282.48K
-6.70%
Mr. Peter E. Boyd
Mr. Peter E. Boyd
Senior Vice President - Information Technology, Human Resources and Communications
Senior Vice President - Information Technology, Human Resources and Communications
268.11K
-3.60%
Ms. Cassie Jung
Ms. Cassie Jung
Chief Operating Officer
Chief Operating Officer
239.09K
-15.12%
Ms. Sherry Korczynski
Ms. Sherry Korczynski
Chief Commercial Officer
Chief Commercial Officer
181.86K
+15.94%
Dr. Gregory B. Brown, M.D.
Dr. Gregory B. Brown, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
75.08K
--
Dr. Marco Taglietti, M.D.
Dr. Marco Taglietti, M.D.
Independent Director
Independent Director
--
--
Mr. Timothy E. Morris, CPA
Mr. Timothy E. Morris, CPA
Independent Director
Independent Director
--
--
Ms. Stephanie Carrington
Ms. Stephanie Carrington
Investor Relations
Investor Relations
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Daniel Barber
Mr. Daniel Barber
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.76M
-4.97%
Ms. Lori J. Braender, J.D.
Ms. Lori J. Braender, J.D.
Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
649.24K
+36.11%
Dr. Carl N. Kraus, M.D.
Dr. Carl N. Kraus, M.D.
Chief Medical Officer
Chief Medical Officer
282.48K
-6.70%
Mr. Peter E. Boyd
Mr. Peter E. Boyd
Senior Vice President - Information Technology, Human Resources and Communications
Senior Vice President - Information Technology, Human Resources and Communications
268.11K
-3.60%
Ms. Cassie Jung
Ms. Cassie Jung
Chief Operating Officer
Chief Operating Officer
239.09K
-15.12%
Ms. Sherry Korczynski
Ms. Sherry Korczynski
Chief Commercial Officer
Chief Commercial Officer
181.86K
+15.94%
收入明細
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
暫無數據
地區USD
名稱
營收
佔比
Ex-United States
5.11M
0.00%
United States
4.89M
0.00%
業務
地區
暫無數據
股東統計
更新時間: 11月4日 週二
更新時間: 11月4日 週二
持股股東
股東類型
持股股東
持股股東
佔比
Crestline Investors, Inc.
8.04%
BlackRock Institutional Trust Company, N.A.
4.83%
The Vanguard Group, Inc.
4.64%
Millennium Management LLC
2.44%
Armistice Capital LLC
2.25%
其他
77.79%
持股股東
持股股東
佔比
Crestline Investors, Inc.
8.04%
BlackRock Institutional Trust Company, N.A.
4.83%
The Vanguard Group, Inc.
4.64%
Millennium Management LLC
2.44%
Armistice Capital LLC
2.25%
其他
77.79%
股東類型
持股股東
佔比
Hedge Fund
15.82%
Investment Advisor
14.81%
Investment Advisor/Hedge Fund
5.82%
Individual Investor
4.78%
Research Firm
3.74%
Private Equity
3.21%
Bank and Trust
0.11%
Insurance Company
0.03%
Pension Fund
0.02%
其他
51.68%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
264
54.55M
45.09%
-6.21M
2025Q2
267
54.90M
55.27%
-2.58M
2025Q1
270
54.42M
54.80%
-3.81M
2024Q4
246
52.68M
57.78%
-5.60M
2024Q3
235
56.04M
61.46%
+1.93M
2024Q2
197
48.34M
53.08%
-1.69M
2024Q1
166
46.95M
51.85%
+18.59M
2023Q4
129
27.01M
40.12%
+751.99K
2023Q3
131
26.75M
41.08%
+3.52M
2023Q2
143
22.79M
40.65%
+3.05M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Crestline Investors, Inc.
9.81M
8.13%
--
--
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
5.89M
4.88%
+448.94K
+8.25%
Jun 30, 2025
The Vanguard Group, Inc.
4.33M
3.59%
+254.95K
+6.26%
Jun 30, 2025
Millennium Management LLC
2.98M
2.47%
+2.72M
+1054.01%
Jun 30, 2025
Armistice Capital LLC
2.75M
2.28%
+2.75M
--
Sep 30, 2024
Perceptive Advisors LLC
2.19M
1.82%
-1.54M
-41.23%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.98M
1.64%
+276.30K
+16.25%
Jun 30, 2025
Barber (Daniel R)
1.76M
1.46%
-91.74K
-4.97%
Sep 26, 2025
Pale Fire Capital SE
1.68M
1.39%
+340.77K
+25.51%
Jun 30, 2025
State Street Investment Management (US)
1.51M
1.25%
-15.36K
-1.01%
Jun 30, 2025
查看更多
持股ETF
更新時間: 11月6日 週四
更新時間: 11月6日 週四
機構名稱
佔比
Invesco NASDAQ Future Gen 200 ETF
0.72%
Federated Hermes MDT Small Cap Core ETF
0.1%
iShares Micro-Cap ETF
0.09%
Invesco Nasdaq Biotechnology ETF
0.07%
ProShares Ultra Nasdaq Biotechnology
0.07%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
iShares Russell 2000 Value ETF
0.02%
ProShares Hedge Replication ETF
0.02%
ProShares UltraPro Russell2000
0.02%
Proshares Ultra Russell 2000
0.02%
查看更多
Invesco NASDAQ Future Gen 200 ETF
佔比0.72%
Federated Hermes MDT Small Cap Core ETF
佔比0.1%
iShares Micro-Cap ETF
佔比0.09%
Invesco Nasdaq Biotechnology ETF
佔比0.07%
ProShares Ultra Nasdaq Biotechnology
佔比0.07%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
佔比0.03%
iShares Russell 2000 Value ETF
佔比0.02%
ProShares Hedge Replication ETF
佔比0.02%
ProShares UltraPro Russell2000
佔比0.02%
Proshares Ultra Russell 2000
佔比0.02%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
